Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients

Annals of Surgery

Volumn 254, Issue 3, 2011, Pages 458-464

  Lazar, Harold L ^a   McDonnell, Marie M ^b   Chipkin, Stuart ^d   Fitzgerald, Carmel ^a   Bliss, Caleb ^c   Cabral, Howard ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b Division of Endocrinology   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE; PIG INSULIN;

ADULT; ADVERSE OUTCOME; AGED; ANGINA PECTORIS; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DEEP STERNAL INFECTION; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; AGGRESSIVE GLYCEMIC CONTROL; ANESTHESIA INDUCTION; BONE INFECTION; CEREBROVASCULAR ACCIDENT; CONTINUOUS INFUSION; CONTROLLED STUDY; INSULIN TREATMENT; MODERATE GLYCEMIC CONTROL; MORBIDITY; PROSPECTIVE STUDY; STERNUM INFECTION; SURGICAL MORTALITY;

AGED; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80052286753     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822c5d78     Document Type: Conference Paper

References (32)

1. Szabo Z, Hakanson E, Svedjeholm R. Early post-operative outcome and medium-term survival in 540 diabetic and 2,239 non-diabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74:712-719. (Pubitemid 35001797)
2. Cohen Y, Raz I, Merin G, et al. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with and without diabetes mellitus. Ann J Cardiol. 1998;81:17-21.
3. Carson JL, Scholz DM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418-423. (Pubitemid 34833154)
4. Jacoby R, Nesto R. Acute myocardial infarction in the diabetic patient, pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992;20:736-744.
5. Malmberg K, Ryden L, Egendic S. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
6. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases ischemic events. Circulation. 2004;109:1497-1502. (Pubitemid 38420177)
7. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infections in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67: 352-362. (Pubitemid 29176984)
8. FurnaryAP, GaoG,Grunkemeier Gl, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021. (Pubitemid 36644877)
9. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project. Endocr Proct. 2004;10(suppl 2):21-33.
10. Lazar HL,McDonnell M, Chipkin S, et al. Executive Summary of the Society of Thoracic Surgeons: Guidelines for blood glucose management during cardiac surgery. Ann Thorac Surg. 2009;87:663-669.
11. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
12. NICE-SUGAR Study InvestigatorsFinfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl JMed. 2009;360:1283-1297.
13. Hermanides J, Uriesendrop TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38: 838-842.
14. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med. 2007;35:S503-S507. (Pubitemid 47312186)
15. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: 9 randomized prospective 6 year study. Diabetes Res Clin Proct. 1995;28:103-117.
16. Action to control Cardiovascular Risk in Diabetes Study Group.Gerstein HC, Miller ME, Byinton RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559. (Pubitemid 351831356)
17. The UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1993;352:854-865.
18. ADVANCE Collaborative Group. Patel A, MacMahond A, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572. (Pubitemid 351831357)
19. Duckworth W, Abraita C, Moritz T, et al. Intensive glucose control and complications in American veterans with type 2 diabetes. New Engl J Med. 2009;360:129-139.
20. Zoungas S, Patel A, Chalmers J, et al. The ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410-1416.
21. Friberg O, Svedjeholm R, Soderquist B, et al. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized control trial. Ann Thorac Surg. 2005;79:153-161. (Pubitemid 40037458)
22. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical/ICU. N Engl J Med. 2006; 354:449-461.
23. Bronkhurst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358: 125-139.
24. The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet. 1998;352:837-857.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
26. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systemic review and meta analysis. Chest. 2010; 137:544-551.
27. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:837-853.
28. Lindstrom T, Jorfeldt L, Tegler L, et al. Hypoglycemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet Med. 1992;9: 536-541.
29. Svensson AM, McGuire DK, Abrahamsson P, et al. Association between hyper and hypoglycemic and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26:1255-1261. (Pubitemid 41435454)
30. Qaseem A, Humphrey LL, Chou R, et al. for the Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients. A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154:260-267.
31. Bhamidipati CM, LaPar DJ, Stukenborg GJ, et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery-bypass grafting. J Thorac Cardiovasc Surg. 2010;141: 1-9.
32. Vlasselaers D,Mesotten D, Langouche L, et al. Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg. 2010;90:22-30.